UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab

Nephrology, dialysis, transplantation, 2021-08, Vol.36 (8), p.1408-1417

2021

Volltextzugriff (PDF)

Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (6), p.920-925

2020

Volltextzugriff (PDF)

Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases

Nephrology, dialysis, transplantation, 2021-03, Vol.36 (7), p.1160-1168

2021

Volltextzugriff (PDF)

The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021

Nephrology, dialysis, transplantation, 2023-02, Vol.38 (3), p.551-561

2023

Volltextzugriff (PDF)

Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results

Nephrology, dialysis, transplantation, 2021-08, Vol.36 (8), p.1474-1483

2021

Volltextzugriff (PDF)

Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations

Nephrology, dialysis, transplantation, 2023-10, Vol.38 (11), p.2637-2651

2023

Volltextzugriff (PDF)

Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS

Nephrology, dialysis, transplantation, 2022-07, Vol.37 (8), p.1400-1410

2022

Volltextzugriff (PDF)

Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group

Nephrology, dialysis, transplantation, 2024-03, Vol.39 (4), p.569-580

2024

Volltextzugriff (PDF)

The management of membranous nephropathy-an update

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (6), p.1033-1042

2022

Volltextzugriff (PDF)

Compliments from complement: a fourth pathway of complement activation?

Nephrology, dialysis, transplantation, 2006-12, Vol.21 (12), p.3374-3376

2006

Volltextzugriff (PDF)

Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)

Nephrology, dialysis, transplantation, 2023-07, Vol.38 (8), p.1807-1816

2023

Volltextzugriff (PDF)

MO246: Belimumab Disrupts Memory B Cell Trafficking in Patients with Systemic Lupus Erythematosus

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (Supplement_3)

2022

Volltextzugriff (PDF)

SaO033EXCESSIVE FORMATION OF NEUTROPHIL EXTRACELLULAR TRAPS HAVE A DIFFERENT ROLE IN THE PATHOGENESIS OF ANCA-ASSOCIATED VASCULITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS

Nephrology, dialysis, transplantation, 2018-05, Vol.33 (suppl_1), p.i328-i329

2018

Volltextzugriff (PDF)

Management of anti-neutrophil cytoplasmic antibody associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 Guidelines/Recommendations

Nephrology, dialysis, transplantation, 2023-05

2023

Volltextzugriff (PDF)

Deposition of IgA in primary IgA nephropathy: it takes at least four to tango

Nephrology, dialysis, transplantation, 2013-04, Vol.28 (4), p.794-797

2013

Volltextzugriff (PDF)

MO257BELIMUMAB ADD-ON THERAPY MOBILIZES MEMORY B CELLS INTO CIRCULATION OF SLE PATIENTS

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

MO251HIGHLY SENSITIVE FLOW CYTOMETRIC DETECTION OF RESIDUAL B-CELLS AFTER RITUXIMAB IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS PATIENTS

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

SO037SIGNIFICANT REDUCTIONS OF PATHOGENIC AUTOANTIBODIES BY SYNERGETIC RITUXIMAB AND BELIMUMAB TREATMENT EFFECTIVELY INHIBITS NEUTROPHIL EXTRACELLULAR TRAPS IN SEVERE, REFRACTORY SLE - THE SYNBIOSE STUDY

Nephrology, dialysis, transplantation, 2017-05, Vol.32 (suppl_3), p.iii22-iii22

2017

Volltextzugriff (PDF)

Role of properdin in complement-mediated kidney diseases

Nephrology, dialysis, transplantation, 2019-05, Vol.34 (5), p.742-750

2019

Volltextzugriff (PDF)

FO055THE EFFECT OF B CELL TARGETED THERAPIES ON AUTOANTIBODIES AND EXCESSIVE NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Nephrology, dialysis, transplantation, 2018-05, Vol.33 (suppl_1), p.i41-i42

2018

Volltextzugriff (PDF)

MO040SYNERGETIC B-CELL IMMUNOMODULATION WITH RITUXIMAB AND BELIMUMAB IS CLINICALLY EFFECTIVE IN SEVERE AND REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - THE SYNBIOSE PROOF-OF-CONCEPT STUDY

Nephrology, dialysis, transplantation, 2017-05, Vol.32 (suppl_3), p.iii59-iii59

2017

Volltextzugriff (PDF)

TO009TARGETED DELIVERY OF LIPOSOMAL PREDNISOLONE AFTER RENAL ISCHEMIA REPERFUSION INJURY IN THE RAT

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (suppl_1), p.i63-i64

2016

Volltextzugriff (PDF)

Demonstration of secretory IgA in kidneys of patients with IgA nephropathy

Nephrology, dialysis, transplantation, 2007-11, Vol.22 (11), p.3191-3195

2007

Volltextzugriff (PDF)

Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-β-independent pathway

Nephrology, dialysis, transplantation, 2004-07, Vol.19 (7), p.1694-1701

2004

Volltextzugriff (PDF)

Is there a role for locally produced complement in renal disease?

Nephrology, dialysis, transplantation, 2000-10, Vol.15 (10), p.1506-1509

2000

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaMale

Zeitschrift / SerieNephrology, Dialysis, Transplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Kollektion

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab

Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic

Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases

The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021

Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results

Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations

Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS

Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group

The management of membranous nephropathy-an update

Compliments from complement: a fourth pathway of complement activation?

Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)

MO246: Belimumab Disrupts Memory B Cell Trafficking in Patients with Systemic Lupus Erythematosus

SaO033EXCESSIVE FORMATION OF NEUTROPHIL EXTRACELLULAR TRAPS HAVE A DIFFERENT ROLE IN THE PATHOGENESIS OF ANCA-ASSOCIATED VASCULITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS

Management of anti-neutrophil cytoplasmic antibody associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 Guidelines/Recommendations

Deposition of IgA in primary IgA nephropathy: it takes at least four to tango

MO257BELIMUMAB ADD-ON THERAPY MOBILIZES MEMORY B CELLS INTO CIRCULATION OF SLE PATIENTS

MO251HIGHLY SENSITIVE FLOW CYTOMETRIC DETECTION OF RESIDUAL B-CELLS AFTER RITUXIMAB IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS PATIENTS

SO037SIGNIFICANT REDUCTIONS OF PATHOGENIC AUTOANTIBODIES BY SYNERGETIC RITUXIMAB AND BELIMUMAB TREATMENT EFFECTIVELY INHIBITS NEUTROPHIL EXTRACELLULAR TRAPS IN SEVERE, REFRACTORY SLE - THE SYNBIOSE STUDY

Role of properdin in complement-mediated kidney diseases

FO055THE EFFECT OF B CELL TARGETED THERAPIES ON AUTOANTIBODIES AND EXCESSIVE NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

MO040SYNERGETIC B-CELL IMMUNOMODULATION WITH RITUXIMAB AND BELIMUMAB IS CLINICALLY EFFECTIVE IN SEVERE AND REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - THE SYNBIOSE PROOF-OF-CONCEPT STUDY

TO009TARGETED DELIVERY OF LIPOSOMAL PREDNISOLONE AFTER RENAL ISCHEMIA REPERFUSION INJURY IN THE RAT

Demonstration of secretory IgA in kidneys of patients with IgA nephropathy

Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-β-independent pathway

Is there a role for locally produced complement in renal disease?

Aktive Filter

Suchergebnisse filtern